Swine flu vaccine yet to hit Delhi markets
June 6th, 2010 - 12:43 pm ICT by IANSNew Delhi, June 6 (IANS) The indigenous swine flu vaccine launched this week is yet to hit the markets in Delhi as against claims by Health Minister Ghulam Nabi Azad that it will be available from Friday.
Manufactured by medicine giant Cadila Healthcare, Vaxiflu-S is an egg-based, single dosed vaccine which gives immunity against the deadly H1N1 virus for a year.
At the launch of the vaccine Thursday, both Azad and Cadila Chairman Pankaj Patel had said that these would be available in the market from Friday.
The situation in the market is, however, different with most of the chemist shops in Delhi not having the stocks.
“We don’t have the vaccine in the market as yet,” said Mukesh, who works with the Batra Medical Corner in Karol Bagh.
North Delhi Chemists’ Association president Ashok Jain told IANS: “Cadila has not marketed it yet. There is no stock available with any stockist in Delhi.”
He was, however, not worried over the delay.
“There isn’t much demand for the vaccine. There have been no recent cases in Delhi, so nobody seems to be concerned about it at present,” Jain added.
The high price tag of the drug is seen as another reason for the low demand.
Said Mukesh: “It is to be priced above Rs.350, no one will spend that much specially as the epidemic has slowed down.”
Four companies — Cadila Healthcare, Serum Institute of India, Bharat Biotech and Panacea Biotech — were granted research aid for developing an indigenous vaccine for the virus which has claimed more than 1,500 lives in the last one year.
The vaccine by Serum Institute is likely to hit the market by the end of this month, while Bharat Biotech and Panacea are likely to launch their versions by July and August, respectively.
No fresh cases of swine flu have been reported in the capital during the last two months.
At least 30 new cases of the flu were reported all over the country last week while four people died.
The highest number of 21 cases was reported from Maharashtra last week.
A total of 31,934 people have been affected by the H1N1 flu in India so far. The casualties from the flu reached 1,531 May 31.
- India-made H1N1 vaccine launched (Lead) - Jun 03, 2010
- Indigenous H1N1 vaccine launched - Jun 03, 2010
- Swine flu vaccine shortage in Delhi - Jul 14, 2010
- Delhi almost swine flu-free, but monsoon could spell trouble - Jun 30, 2010
- India to develop swine flu vaccine by 2010: Azad - Nov 24, 2009
- India developing indigenous swine flu vaccine (Interview) - Aug 09, 2009
- India will import swine flu vaccine if developed anywhere - Aug 10, 2009
- Swine flu vaccine in 'four to seven months', says government - Aug 07, 2009
- India to develop swine flu vaccine by early next year: Azad - Dec 26, 2009
- Pharma firms to conduct H1N1 vaccine human trials in India - Dec 08, 2009
- India to unveil second swine flu vaccine - Jul 09, 2010
- Swine flu vaccine in six months: Health ministry - Jun 12, 2009
- Swine flu immunity just a sniff away - Jul 20, 2010
- Swine flu shots must for cardiac patients - Jul 03, 2010
- India may have swine flu vaccine by September - Aug 04, 2009
Tags: ashok jain, association president, bharat, cadila healthcare, chemist shops, chemists, ghulam nabi azad, health minister, immunity, karol bagh, last two months, launch, medical corner, mukesh, north delhi, panacea, pankaj patel, price tag, serum institute of india, swine flu vaccine